Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM

J P DiSanto1, J Y Bonnefoy, J F Gauchat

  • 1INSERM U 132, Hôpital Necker-Enfants Malades, Paris, France.

Nature
|February 11, 1993
PubMed
Summary

Defects in CD40 ligand (CD40L) expression cause hyper-IgM immunodeficiency (HIGM1). This study found mutations in the CD40L gene in male children, explaining their immunoglobulin isotype switch defects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD2-induced apoptosis in activated human peripheral T cells: a Fas-independent pathway that requires early protein tyrosine phosphorylation.

Journal of immunology (Baltimore, Md. : 1950)·1996
Same author

Lack of detectable defect in DNA double-strand break repair and DNA-dependent protein kinase activity in radiosensitive human severe combined immunodeficiency fibroblasts.

European journal of immunology·1996
Same author

gamma-c gene transfer into SCID X1 patients' B-cell lines restores normal high-affinity interleukin-2 receptor expression and function.

Blood·1996
Same author

Clinical, hematologic, and biochemical features of a syndrome in Bernese mountain dogs characterized by hepatocerebellar degeneration.

Journal of the American Veterinary Medical Association·1996
Same author

A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Société Française de Greffe de Moelle Osseuse.

British journal of haematology·1996
Same author

Radiommunological measurement of leptin in plasma of obese and diabetic human subjects.

Endocrinology·1996

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • B-cell immunoglobulin isotype switching requires T-cell cytokines and CD40-CD40L interaction.
  • CD40 ligand (CD40L) is crucial for B-cell activation and differentiation.
  • Hyper-IgM immunodeficiency (HIGM1) localizes to the CD40L gene region on the X chromosome.

Purpose of the Study:

  • To investigate the role of CD40L in hyper-IgM immunodeficiency (HIGM1).
  • To determine if mutations in the CD40L gene are responsible for HIGM1.

Main Methods:

  • Analysis of CD40L expression in patients with HIGM1.
  • Genetic analysis of CD40L transcripts, including deletion and point mutation screening.
  • Correlation of genetic findings with clinical phenotype.

Related Experiment Videos

Main Results:

  • Four unrelated male children with HIGM1 exhibited absent CD40L expression.
  • Mutations, including deletions and point mutations, were identified in the extracellular domain of the CD40L gene in these patients.
  • These genetic alterations directly correlate with the observed immunoglobulin isotype switch defects.

Conclusions:

  • Lack of CD40L expression due to genetic mutations is the molecular basis for HIGM1.
  • This finding clarifies the pathogenesis of this primary immunodeficiency.
  • Highlights the critical role of CD40L in adaptive immunity and B-cell development.